Korten Pharmaceuticals Private Limited, a active private limited company, was established on 05 November 1990 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1990PTC058797. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
It upholds a compliant status. Employing 184 professional, Its leadership includes Rahul Ashokkumar Jain (Director), Uttamchand Kesharimal Jain (Director), Pravin Keshrimal Jain (Director). Past directors included Madhav Laxman Deshpande, Neelam Sandeep Mhatre, Kirti Shantilal Sheth. It holds ₹1.40 Cr open charges and ₹50.42 Cr settled loans. Its latest AGM occurred on 19 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gala No.40,Damji Shamji Industrial Complex Mahakali Caves Road, Andheri East, Mumbai, Maharashtra, 400093.
U24239MH1990PTC058797
058797
05 November 1990
₹3.00 Cr
₹3.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Korten Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Ashokkumar Jain | Director | 05 Jan 2013 | Current |
| Uttamchand Kesharimal Jain | Director | 05 Jan 2013 | Current |
| Pravin Keshrimal Jain | Director | 15 Feb 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Mar 2013 | Past |
| Pramod Abcsdd | Director | 11 Jul 2014 | Past |
| Pramod Abcsdd | Managing Director | 31 Mar 2008 | Past |
| Pramod Abcsdd | Company Secretary | 06 Apr 2008 | Past |
| Pramod Abcsdd | Director | 18 Mar 2013 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Korten Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 28.73% increase. The company also saw a substantial improvement in profitability, with a 103.91% increase in profit. The company's net worth Soared by an impressive increase of 31.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Korten Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹14,000,000.00
₹504,248,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Feb 1996 | The Hongkong And Shanghai Banking Corporation Limited | ₹5.00 M | Open |
| 05 Feb 1996 | The Hongkong And Shanghai Banking Corporation Limited | ₹5.00 M | Open |
| 02 Nov 1994 | The Hongkong And Shanghai Banking Corporation Limited | ₹4.00 M | Open |
| 04 Jul 2019 | Others | ₹1.85 Cr | Satisfied |
| 05 Nov 2016 | Others | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Korten Pharmaceuticals has a workforce of 184 employees as of Mar 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Korten Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Korten Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Korten Pharmaceuticals Private Limited last Annual general meeting of members was held on 19 Sep 2025 as per latest MCA records. was completed.
The activity Korten Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Progress on A charge registered on 28 Feb 1995 via Charge ID 90152463 with Maharashtra State Financial Corporation was fully satisfied on 30 Aug 2022. was documented.
A charge registered on 28 Jun 2002 via Charge ID 90153903 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 24 Jun 2021. was recorded as a recent event.
The activity A charge registered on 22 Sep 2001 via Charge ID 90153842 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 24 Jun 2021. was completed.
Progress on A charge registered on 20 Sep 2001 via Charge ID 90154654 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 24 Jun 2021. was documented.
The CIN of Korten Pharmaceuticals Private Limited is U24239MH1990PTC058797.
Korten Pharmaceuticals Private Limited is headquartered at Gala No.40,Damji Shamji Industrial Complex Mahakali Caves Road, Andheri East, Mumbai, Maharashtra, 400093.
Korten Pharmaceuticals Private Limited was incorporated on 05 November 1990.
The current directors of Korten Pharmaceuticals Private Limited are
The primary industry of Korten Pharmaceuticals Private Limited is Manufacturing.
Korten Pharmaceuticals Private Limited is unlisted.
The authorized capital of Korten Pharmaceuticals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Korten Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX